Page 17 of 18
The Journal of Organic Chemistry
1
2
3
4
5
6
7
8
9
2 (a) Ericksson, B. I.; Carlsson, S.; Halvarsson, M.; Risberg, B.; Mattsson, C. Thromb. Haemostasis 1997,
78, 1404–1407. (b) AstraZeneca, PCT Int. Appl., WO 00/41716, 2000. (c) Wellington, K.; Scott, L. J.
Drugs 2003, 63, 2613–2621.
3 (a) Lemaire, S.; Tulkens, P. M.; Van Bambeke F. Antimicrob. Agents Chemother. 2011, 55, 649–658.
(b) Larkin, J.; Ascierto. P. A.; Dréno, B.; Atkinson, V.; Liszkay, G.; Maio, M.; Mandalá, M.; Demidov,
L.; Stroyakovskiy, D.; Thomas, L.; de la CruzꢀMerino, L.; Dutriaux, C.; Garbe, C.; Sovak, M. A.; Chang,
I.; Choong, N.; Hack, S. P.; McArthur, G. A.; Ribas, A. N. Engl. J. Med. 2014, 371, 1867–1876. (c)
Fridman, J. S.; Scherle, P. A.; Collins, R.; Burn, T. C.; Li, Y.; Li, J.; Covington, M. B.; Thomas, B.;
Collier, P.; Favata, M. F.; Wen, X.; Shi, J.; McGee, R.; Haley, P. J.; Shepard, S.; Rodgers, J. D.;
Yeleswaram, S.; Hollis, G.; Newton, R. C.; Metcalf, B.; Friedman, S. M.; Vaddi, K. J. Immunol. 2010,
184, 5298–5307.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
4 Shi, M.; Jiang, J.ꢀK. Tetrahedron: Asymmetry 1999, 10, 1673–1679.
5 (a) Brandi, A.; Cicchi, S.; Cordero, F. M. Chem. Rev. 2008, 108, 3988–4035. (b) Rousseau, G.; Robin,
S. FourꢀMembered Heterocycles: Structure and Reactivity. In Modern Heterocyclic Chemistry, 1st ed.;
AlzerezꢀBuilla, J., Vaquero, J. J., Barluenga, J., Eds.; WileyꢀVCH; Weinheim, 2011; Vol. 1, pp 163ꢀ268.
(c) Bott, T. M.; West, F. G. Heterocycles 2012, 84, 223–264.
6 (a) Ghorai, M. K.; Das, K.; Kumar, A. Tetrahedron Lett. 2007, 48, 2471–2475. (b) Martínez, R. F.;
Fleet, G. W. J. Tetrahedron: Asymmetry 2014, 25, 373–380. (c) Hodgson, D. M.; Mortimer, C. L.;
McKenna, J. M. Org. Lett. 2015, 17, 330–333. (d) Jensen, K. L.; Nielsen, D .U.; Jamison, T. F. Chem.
Eur. J. 2015, 21, 7379–7383. (e) Kapoor, R.; Chawla, R.; Singh, S.; Yadav. L.D.S. Synlett 2012, 23,
1321–1326. (f) He, G.; Zhao, Y.; Zhang, S.; Lu, C.; Chen, G. J. Am. Chem. Soc. 2012, 134, 3–6.
7 The listed prices for this material are prohibitively expensive. (S)ꢀ2ꢀmethylazetidine HCl: 1 g/$1995
from a single vendor. Prices generally range $300ꢀ$1000 for 1 g of racemic 2ꢀmethylazetidine HCl.
8 (a) Vaughn, W. R.; Klonowski, R. S.; McElhinney, R. S.; Millward, B. B. J. Org. Chem. 1961, 26, 138–
144. (b) Malik, S.; Nadir, U. K. Synlett 2008, 1, 0108–0110. (c) Kenis, S.; D’hooghe, M.; Verniest, G.;
Anh Dang Thi, T.; Pham The, C.; Van Nguyes, T. V.; De Kimpe, N. J. Org. Chem. 2012, 77, 5982–5992.
(d) Drouillat, B.; d’Aboville, E.; Bourdreux, F.; Couty, F. Eur. J. Org. Chem. 2014, 1103–1109. (e)
Hansen, C. P.; Jensen, A. A.; Christensen, J. K.; Balle, T.; Lijefors, T.; Frølund, B. J. Med. Chem. 2008,
51, 7380–7395. (f) Nadir, U. K.; Sharma, R. L.; Koul, V. K. J. Chem. Soc., Perkin Trans. 1 1991, 2015–
2019.
9 The reported methods for accessing racemic 2ꢀmethylazetidine are also generally not suitable for largeꢀ
scale application. Moreover, while the resolution of racemic Nꢀbenzyl 2ꢀmethylazetidine as a CSA or
tartaric acid salt has been reported, no experimental details were provided and the material loss inherent
to this process was undesirable, see: Miyamae, H.; Enomoto, K.; Tsuboyama, S.; Yajima, KI.; Sassa, M.;
Kobayashi, K. X-Ray Structure Analysis Online 2003, 19, 53–54.
10 (a) Cowart, M. D.; Ku, Y.ꢀY; Chang, S.ꢀJ.; Fernando, D. P.; Grieme, T. A.; Altenbach, R. J. Patent
App.: US2004/224953 A1, 2004. (b) Nabeya, A.; Endo, T.; Nishiguchi, T.; Hori, K. J. Org. Chem. 1999,
64, 5686–5690. (c) Shustov. G. V.; Rauk, A. J. Am. Chem. Soc. 1995, 117, 928–934.
11 Marinetti, A.; Hubert, P.; Genêt, J.ꢀP. Eur. J. Org. Chem. 2000, 1815–1820.
12 Hillier, M. C.; Chen, Cꢀy. J. Org. Chem. 2006, 71, 7885–7887.
13 (a) Liu, Z.; Jenkinson, S. F.; Vermaas, T.; Adachi, I.; Wormald, M. R.; Hata, Y.; Kurashima, Y.; Kaji,
A.; Yu, C.ꢀY.; Kato, A.; Fleet, G. W. J. J. Org. Chem. 2015, 80, 4244–4258. (b) Martínez, R. F.; Fleet, G.
W. J. Tetrahedron: Asymmetry 2014, 25, 373–380. (c) Glawar, A. F. G.; Jenkinson, S. F.; Thompson, A.
17
ACS Paragon Plus Environment